UPI News Alert Uroplasty (UPI) 2.30 12/25/2014 15:50:35

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Uroplasty (UPI) 2.30 $UPI

UPI SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Uroplasty, Inc. Regarding the Fairness of the Sale of the Company to Vision-Sciences, Inc.
Business Wire - Wed Dec 24, 11:19AM CST
Levi & Korsinsky is investigating the Board of Directors of Uroplasty, Inc. ("Uroplasty" or "the Company" (NasdaqCM: UPI) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Vision-Sciences, Inc. (NasdaqCM: VSCI).
VSCI: 0.76 (-0.07), UPI: 2.30 (unch)

Nasdaq stocks posting largest volume increases
AP - Tue Dec 23, 5:07PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
INTG: 17.90 (+0.01), NICK: 14.80 (+0.20), ADXS: 7.57 (+0.50), WBKC: 23.47 (+0.03), SOCB: 7.20 (+0.03), CBIN: 27.50 (-0.28), UPI: 2.30 (unch), CTIB: 3.74 (-0.06), SONA: 11.29 (unch)

UROPLASTY, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Vision-Sciences, Inc.
Business Wire - Tue Dec 23, 10:40AM CST
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Uroplasty, Inc. ("Uroplasty" (NASDAQ: UPI) concerning the sale to Vision-Sciences, Inc. (NasdaqCM: VSCI). Under the terms of the agreement, Uroplasty shareholders will receive 3.6331 shares of VSCI for each share owned. Based on the closing price of both stocks before the deal was announced, the consideration is valued at approximately $3.67, which is only a 15.6% premium and significantly lower than the 52-week high. Also, at least one analyst estimated a value of $6.00 per share.
VSCI: 0.76 (-0.07), UPI: 2.30 (unch)

UPI SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Uroplasty, Inc. Regarding the Fairness of the Sale of the Company to Vision-Sciences, Inc. -- UPI
PR Newswire - Tue Dec 23, 10:22AM CST
Levi & Korsinsky is investigating the Board of Directors of Uroplasty, Inc. ("Uroplasty" or "the Company" (NasdaqCM: UPI) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Vision-Sciences, Inc. (NasdaqCM: VSCI).
VSCI: 0.76 (-0.07), UPI: 2.30 (unch)

UROPLASTY, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
PR Newswire - Mon Dec 22, 11:42AM CST
Rigrodsky & Long, P.A.:
VSCI: 0.76 (-0.07), UPI: 2.30 (unch)

UPI SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Uroplasty, Inc. Regarding the Fairness of the Sale of the Company to Vision-Sciences, Inc.
Business Wire - Mon Dec 22, 9:42AM CST
Levi & Korsinsky is investigating the Board of Directors of Uroplasty, Inc. ("Uroplasty" or "the Company" (NasdaqCM: UPI) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Vision-Sciences, Inc. (NasdaqCM: VSCI).
VSCI: 0.76 (-0.07), UPI: 2.30 (unch)

Uroplasty and Vision-Sciences to Merge, Creating Innovative Medical Device Company Positioned for Growth
GlobeNewswire - Mon Dec 22, 6:00AM CST
All-Stock Combination Creates New Company with Expanded Product Offerings in Urology
VSCI: 0.76 (-0.07), UPI: 2.30 (unch)

Uroplasty and Vision-Sciences to Merge, Creating Medical Device Company Positioned for Growth
PR Newswire - Mon Dec 22, 6:00AM CST
Uroplasty, Inc. (NASDAQ: UPI) and Vision-Sciences, Inc. (NASDAQ: VSCI) entered into a definitive merger agreement under which the two companies will combine in an all-stock transaction to create a new company expected to generate revenue of approximately $50 million for the fiscal year beginning April 1, 2015.
VSCI: 0.76 (-0.07), UPI: 2.30 (unch)

Uroplasty To Participate In The Canaccord Genuity 2014 Medical Technology & Diagnostics Forum
PR Newswire - Thu Nov 13, 6:00AM CST
Uroplasty, Inc. (NASDAQ: UPI) a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that it will participate in the Canaccord Genuity 2014 Medical Technology & Diagnostics Forum on Thursday, November 20.
UPI: 2.30 (unch)

Uroplasty FQ2 revenues up 12%
Seeking Alpha - at Seeking Alpha - Fri Oct 24, 8:04AM CDT

UPI: 2.30 (unch)

Uroplasty's (UPI) CEO Robert Kill on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 23, 7:06PM CDT

UPI: 2.30 (unch)

Uroplasty beats by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 3:46PM CDT

UPI: 2.30 (unch)

Uroplasty Reports Record Fiscal Second Quarter Revenue
PR Newswire - Thu Oct 23, 3:01PM CDT
Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today reported financial results for the fiscal 2015 second quarter ended September 30, 2014.
UPI: 2.30 (unch)

Healthcare Industry Leader Kenneth H. Paulus Joins Uroplasty's Board of Directors
PR Newswire - Wed Oct 15, 6:00AM CDT
Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, announced today that Kenneth H. Paulus has been appointed to the Company's Board of Directors effective October 15, 2014. Mr. Paulus will chair the Board's compensation committee and serve on the nominating committee.
UPI: 2.30 (unch)

Uroplasty to Announce Second Quarter Fiscal Year 2015 Financial Results on October 23, 2014
PR Newswire - Thu Oct 09, 6:00AM CDT
Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, will release financial results for the second quarter ended September 30, 2014 after the market close on Thursday, October 23, 2014.
UPI: 2.30 (unch)

Uroplasty To Participate In The 5th Annual Craig-Hallum Alpha Select Conference
PR Newswire - Wed Sep 10, 6:00AM CDT
Uroplasty, Inc. (NASDAQ: UPI) a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that it will participate in the 5th Annual Craig-Hallum Alpha Select Conference on Thursday, September 18.
UPI: 2.30 (unch)

Electromed, Inc. Names Lee Jones to its Board of Directors
Business Wire - Tue Sep 02, 3:30PM CDT
Electromed, Inc. (NASDAQ: ELMD), announced today that its Board of Directors has elected Lee Jones to the Board. Ms. Jones has served as the President and Chief Executive Officer of Rebiotix Inc. since 2011 and as a director of Uroplasty, Inc. since 2006.
UPI: 2.30 (unch), ELMD: 2.54 (+0.01)

Uroplasty To Participate In Canaccord Genuity 34th Annual Growth Conference
PR Newswire - Wed Aug 06, 6:00AM CDT
Uroplasty, Inc. (NASDAQ: UPI) a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that it will participate in the Canaccord Genuity 34th Annual Growth Conference on Wednesday, August 13.
UPI: 2.30 (unch)

Uroplasty Reports Fiscal First Quarter Results
PR Newswire - Thu Jul 24, 3:01PM CDT
Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today reported financial results for the fiscal 2015 first quarter ended June 30, 2014.
UPI: 2.30 (unch)

Uroplasty To Announce First Quarter Fiscal Year 2015 Financial Results On July 24, 2014
PR Newswire - Thu Jul 10, 6:00AM CDT
Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, will release financial results for the first quarter ended June 30, 2014 after the market close on Thursday, July 24, 2014.
UPI: 2.30 (unch)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mike Blyth’s Hall of Fame Honors a Builder’s Legacy

Updated Category News Views 147

Recognition earned in the hangar, not a boardroom Aircraft design has a ruthless way of exposing empty talk, which is why Mike Blyth’s November 11 induction into the EAA Homebuilders Hall of Fame carries real weight. The Experimental Aircraft Association’s honor, presented in the Eagle Hangar at the EAA Aviation Museum in Oshkosh, Wisconsin, recognizes a career built...

Continue Reading
LASIK Cost Math Deserves a Careful Second Look Today

Updated Category News Views 114

Thirty years of lens purchases can become a nasty tab Contact-lens spending has a funny way of staying invisible until somebody stacks the receipts into one ugly pile. A new cost-of-vision analysis from the surgeon advisory board of BestLASIKSurgeons.com says the average American contact-lens wearer may spend between $22,500 and $30,000 on corrective eyewear across 30...

Continue Reading
SanMar’s Lott Tops Promo Products Power 50 Again in 2026

Updated Category News Views 102

Branded hoodies and logo tumblers rarely make Wall Street’s pulse race, but the numbers behind them deserve a hard look. Jeremy Lott, president and CEO of SanMar, was named the most influential leader in the U.S. promotional-products business for the second consecutive year, taking No. 1 in the 2026 Counselor Power 50 ranking. Awards can be fluff. A repeat win beside...

Continue Reading
Onward Therapeutics Secures $28M to Bolster Oncology R&D

Updated Category News Views 76

Cashing In to Conquer Cancer In the risk-laden world of biotech, Onward Therapeutics has just bagged a hefty NT$900 million—roughly US$28 million—from its Series B financing. That's not pocket change and speaks to the level of confidence their backers have, even as they plant their global headquarters firmly in Taipei since relocating from Switzerland. A Deep Dive...

Continue Reading
Docusign Pushes Contract Data Into ChatGPT Sales Tools

Updated Category News Views 179

Contracts are where sales momentum goes to get lost, buried under old PDFs, approval chains, and somebody’s half-finished CRM note. Docusign’s November 17, 2026 launch is a sensible attempt to drag that information into the place sellers may increasingly spend their working day: ChatGPT for Sales. The company’s new plugin lets a sales rep pull agreement intelligence...

Continue Reading
MacDill Mold Case Puts Privatized Housing on Notice

Updated Category News Views 38

Four hundred fifty-four people are a hard number to shrug off. The expanded civil case over alleged toxic mold conditions at MacDill Air Force Base now covers 105 military families, up from 39 households when it was filed in September 2025. Their complaint against The Michaels Organization and affiliated entities may be the largest known military-housing lawsuit in the...

Continue Reading
Toledo Crosswalk Death Lawsuit Raises Hard Questions

Updated Category News Views 237

A painted crosswalk is supposed to mean something, and that is the grim center of the lawsuit filed over Judy Tanner’s death in Toledo. Tanner, 20, was walking home from work on September 10, 2026, when she was struck and killed while crossing the street. Her estate is now suing, alleging that the 31-year-old driver failed to yield as Tanner legally used the crosswalk....

Continue Reading
Concierto's Azure Push Puts Sovereignty on Display

Updated Category News Views 78

Sovereignty has become the corporate cloud world's favorite hard-edged word. Concierto is taking that word straight onto the Microsoft Ignite 2026 floor, and frankly, it is a sensible place to make the case. The company, part of Trianz, will appear as a Gamechanger Sponsor from November 17 through 20 at San Francisco's Moscone Center, showing its platform at Booth #5435....

Continue Reading
Max y Noelia Explore Trade at 9th CIIE in Shanghai

Updated Category News Views 60

Influencers at the Heart of Global Trade Exploration Makin' their debut on the big stage of the 9th China International Import Expo (CIIE), Mexican influencers Max y Noelia found themselves caught in a whirlwind of trade and cultural exchanges over in Shanghai. These digital mavens aren't just snapping selfies. Nope, they're capturing the very essence of international...

Continue Reading
Red Cat Stock Drama: Revenue Targets and Legal Waves

Updated Category News Views 110

Red Cat's Revenue Predictions Crash and Burn Sitting there on August 6, 2026, Red Cat Holdings had everyone believing they were on a fast track to hitting a hefty revenue target: $150–$180 million for FY2026. CEO Jeffrey Thompson didn't mince words, boasting confidence like a captain before a storm. Fast forward three months, and they're waving the white flag, tossing...

Continue Reading

Top 5 Most Recently Viewed Articles

B. Riley Financial Partners with Oaktree to Enhance Services

Updated Category News Views 55

B. Riley Financial and Oaktree: A Strategic Collaboration B. Riley Financial, Inc. (NASDAQ: RILY) is thrilled to announce a new partnership with Oaktree Capital Management, L.P. to strengthen its Great American Group businesses. Definitive Agreement Signed The companies have finalized a definitive agreement enabling a collaboration through a newly formed holding company...

Continue Reading
General Motors Faces Changes: A Shift in EV Incentive Strategy

Updated Category News Views 348

General Motors Adjusts EV Incentives General Motors Co. (NYSE: GM) has decided to revise its plans concerning electric vehicle (EV) incentives after initially suggesting options beyond the Federal EV Credit deadline. This shift comes shortly after rising scrutiny from political figures around the implications of such financial strategies. Concerns Raised by Key...

Continue Reading
Pacsun Unveils Stylish New Sunglasses Collection for All

Updated Category News Views 327

Pacsun Launches an Elegant Sunglass Collection Pacsun has taken a bold step in expanding its product range by introducing a new collection of premium sunglasses. This unisex line represents the brand's commitment to elevating its accessory offerings, appealing to a broader audience of style-conscious consumers. Innovative Designs in Sunglass Fashion With the release of...

Continue Reading
Exploring the Rapid Growth of the Opioid Use Disorder Market

Updated Category News Views 216

Understanding the Opioid Use Disorder Market and Its Promising Growth The opioid crisis represents a major public health challenge, significantly impacting communities across the globe. According to research, the Opioid Use Disorder Market was evaluated at approximately USD 3.7 billion recently, with an exciting projection to surge to USD 9.02 billion by 2032. This...

Continue Reading
Artea Bankas Secures ECB Approval for Stock Buyback Initiative

Updated Category News Views 242

Artea Bankas Secures ECB Approval for Stock Buyback Initiative AB Artea Bankas has recently gained essential approval from the European Central Bank (ECB) allowing the bank to buy back up to 4,500,000 of its own shares, marking a significant step in enhancing shareholder value. This buyback program is anticipated to commence within one year, demonstrating the bank's...

Continue Reading